Literature DB >> 25387974

Human cytochrome P450 and personalized medicine.

Qi Chen1, Dongqing Wei.   

Abstract

Personalized medicine has become a hot topic ascribed to the development of Human Genome Project. And currently, bioinformatics methodology plays an essential role in personal drug design. Here in this review we mainly focused on the basic introduction of the SNPs of human drug metabolic enzymes and their relationships with personalized medicine. Some common bioinformatics analysis methods and latest progresses and applications in personal drug design have also been discussed. Thus bioinformatics studies on SNPs of human CYP450 genes will contribute to indicate the most possible genes that are associated with human diseases and relevant therapeutic targets, identify and predict the drug efficacy and adverse drug response, investigate individual gene specific properties and then provide personalized and optimal clinic therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25387974     DOI: 10.1007/978-94-017-9245-5_20

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.

Authors:  Nicholas Toupin; Sean J Steinke; Sandeep Nadella; Ao Li; Thomas N Rohrabaugh; Eric R Samuels; Claudia Turro; Irina F Sevrioukova; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2021-06-10       Impact factor: 16.383

2.  Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case-control pharmacokinetic study.

Authors:  Navid Neyshaburinezhad; Mohammadreza Rouini; Nooshin Shirzad; Alireza Esteghamati; Manouchehr Nakhjavani; Soha Namazi; Yalda H Ardakani
Journal:  MethodsX       Date:  2020-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.